Literature DB >> 25925607

Attitudes and Knowledge of Maternal-Fetal Medicine Fellows Regarding Noninvasive Prenatal Testing.

Paul Swaney1,2, Emily Hardisty2, Lauren Sayres3, Samantha Wiegand2, Neeta Vora4.   

Abstract

Using cell-free DNA in maternal serum to detect fetal aneuploidy has been shown to have high sensitivity and specificity. The purpose of this study was to assess attitudes and knowledge of Maternal-Fetal Medicine (MFM) fellows regarding noninvasive prenatal testing (NIPT). A 13 question survey was sent via listserv to US-based MFM fellows. One hundred sixteen fellows responded, a 42.3% response rate, with >75% reporting they are comfortable ordering NIPT. Most (82%) preferred that a patient discuss options with a provider or genetic counselor. Three common methods used to learn about NIPT were: formal educational activities (n = 78, 69%), self-review of the literature (n = 76, 67%), and discussions with peers (n = 73, 65%). On questions related to trisomy 21, accuracy was >70%. However, accuracy was lower regarding use in twin pregnancies (42%) and monosomy X screening (50%).

Entities:  

Keywords:  Attitudes; Cell free fetal DNA; Education; Knowledge; Noninvasive prenatal testing

Mesh:

Year:  2015        PMID: 25925607     DOI: 10.1007/s10897-015-9844-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  14 in total

1.  Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes.

Authors:  Ronald J Wapner; Joshua E Babiarz; Brynn Levy; Melissa Stosic; Bernhard Zimmermann; Styrmir Sigurjonsson; Nicholas Wayham; Allison Ryan; Milena Banjevic; Phil Lacroute; Jing Hu; Megan P Hall; Zachary Demko; Asim Siddiqui; Matthew Rabinowitz; Susan J Gross; Matthew Hill; Peter Benn
Journal:  Am J Obstet Gynecol       Date:  2014-12-02       Impact factor: 8.661

2.  Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.

Authors:  Diana W Bianchi; Lawrence D Platt; James D Goldberg; Alfred Z Abuhamad; Amy J Sehnert; Richard P Rava
Journal:  Obstet Gynecol       Date:  2012-05       Impact factor: 7.661

Review 3.  Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.

Authors:  Karina L Brierley; Erica Blouch; Whitney Cogswell; Jeanne P Homer; Debbie Pencarinha; Christine L Stanislaw; Ellen T Matloff
Journal:  Cancer J       Date:  2012 Jul-Aug       Impact factor: 3.360

4.  Physicians' preparedness for integration of genomic and pharmacogenetic testing into practice within a major healthcare system.

Authors:  Christina G Selkirk; Scott M Weissman; Andy Anderson; Peter J Hulick
Journal:  Genet Test Mol Biomarkers       Date:  2013-02-07

5.  Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation.

Authors:  Lauren C Sayres; Megan Allyse; Mary E Norton; Mildred K Cho
Journal:  Prenat Diagn       Date:  2011-07-27       Impact factor: 3.050

6.  DNA sequencing versus standard prenatal aneuploidy screening.

Authors:  Diana W Bianchi; R Lamar Parker; Jeffrey Wentworth; Rajeevi Madankumar; Craig Saffer; Anita F Das; Joseph A Craig; Darya I Chudova; Patricia L Devers; Keith W Jones; Kelly Oliver; Richard P Rava; Amy J Sehnert
Journal:  N Engl J Med       Date:  2014-02-27       Impact factor: 91.245

Review 7.  Ethical challenges in providing noninvasive prenatal diagnosis.

Authors:  Peter A Benn; Audrey R Chapman
Journal:  Curr Opin Obstet Gynecol       Date:  2010-04       Impact factor: 1.927

8.  Massively parallel sequencing of maternal plasma DNA in 113 cases of fetal nuchal cystic hygroma.

Authors:  Diana W Bianchi; Tracy Prosen; Lawrence D Platt; James D Goldberg; Alfred Z Abuhamad; Richard P Rava; Amy J Sehnert
Journal:  Obstet Gynecol       Date:  2013-05       Impact factor: 7.661

9.  Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.

Authors:  Sharon E Plon; H Paul Cooper; Bethany Parks; Shweta U Dhar; P Adam Kelly; Armin D Weinberg; Stephanie Staggs; Tao Wang; Susan Hilsenbeck
Journal:  Genet Med       Date:  2011-02       Impact factor: 8.822

10.  Integration of targeted sequencing and NIPT into clinical practice in a Chinese family with maple syrup urine disease.

Authors:  Yanqin You; Yan Sun; Xuchao Li; Yali Li; Xiaoming Wei; Fang Chen; Huijuan Ge; Zhangzhang Lan; Qian Zhu; Ying Tang; Shujuan Wang; Ya Gao; Fuman Jiang; Jiaping Song; Quan Shi; Xuan Zhu; Feng Mu; Wei Dong; Vince Gao; Hui Jiang; Xin Yi; Wei Wang; Zhiying Gao
Journal:  Genet Med       Date:  2014-03-06       Impact factor: 8.822

View more
  8 in total

1.  Video education about genetic privacy and patient perspectives about sharing prenatal genetic data: a randomized trial.

Authors:  Christian M Parobek; Margaret M Thorsen; Phinnara Has; Paula Lorenzi; Melissa A Clark; Melissa L Russo; Adam K Lewkowitz
Journal:  Am J Obstet Gynecol       Date:  2022-03-26       Impact factor: 10.693

2.  Family experiences and attitudes about receiving the diagnosis of sex chromosome aneuploidy in a child.

Authors:  Kirsten A Riggan; Sharron Close; Megan A Allyse
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-03-17       Impact factor: 3.908

3.  NIPT and Informed Consent: an Assessment of Patient Understanding of a Negative NIPT Result.

Authors:  Julie L Piechan; Karrie A Hines; Daniel L Koller; Kristyne Stone; Kimberly Quaid; Wilfredo Torres-Martinez; Divya Wilson Mathews; Tatiana Foroud; Lola Cook
Journal:  J Genet Couns       Date:  2016-04-01       Impact factor: 2.537

4.  Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2019-02-19

5.  Obstetrical provider knowledge and attitudes towards cell-free DNA screening: results of a cross-sectional national survey.

Authors:  Wilson V Chan; Jo-Ann Johnson; R Douglas Wilson; Amy Metcalfe
Journal:  BMC Pregnancy Childbirth       Date:  2018-01-23       Impact factor: 3.007

6.  Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.

Authors:  Olivia Miu Yung Ngan; Huso Yi; Samuel Yeung Shan Wong; Daljit Sahota; Shenaz Ahmed
Journal:  BMC Pregnancy Childbirth       Date:  2017-09-05       Impact factor: 3.007

7.  Service provision of non-invasive prenatal testing for Down syndrome in public and private healthcare sectors: a qualitative study with obstetric providers.

Authors:  Olivia Miu Yung Ngan; Huso Yi; Shenaz Ahmed
Journal:  BMC Health Serv Res       Date:  2018-09-21       Impact factor: 2.655

Review 8.  Sex selection and non-invasive prenatal testing: A review of current practices, evidence, and ethical issues.

Authors:  Hilary Bowman-Smart; Julian Savulescu; Christopher Gyngell; Cara Mand; Martin B Delatycki
Journal:  Prenat Diagn       Date:  2019-10-10       Impact factor: 3.050

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.